Literature DB >> 6115105

The action of batulinum toxin at the neuromuscular junction.

L C Sellin.   

Abstract

Botulism results from the action of a protein neurotoxin (mol. wt. congruent to 150,000) produced by the bacterium Clostridium botulinum, of which there are eight known strains. Botulinum neurotoxin is the most potent biological toxin known, having a median lethal dose of 5--50 ng/kg body weight. The primary site of action of botulinum toxin is the cholinergic nerve terminal, where it blocks the release of the neurotransmitter acetylcholine. Death usually results from respiratory failure. Nonlethal doses of botulinum toxin can induce sprouting of the nerve terminal and have significant postsynaptic effects, including muscle atrophy and alterations in the membrane electrical properties of the muscle fiber. There is no universally available treatment for botulinum intoxication. However, immunotherapeutic and chemotherapeutic procedures are not being developed and will be discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6115105

Source DB:  PubMed          Journal:  Med Biol        ISSN: 0302-2137


  19 in total

1.  Neurophysiological observations on the effects of botulinum toxin treatment in patients with dystonic blepharospasm.

Authors:  J Valls-Sole; E S Tolosa; G Ribera
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

2.  A double blind trial of botulinum toxin "A" in torticollis, with one year follow up.

Authors:  A P Moore; L D Blumhardt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

3.  Subcutaneous botulinum toxin type A inhibits regional sweating: an individual observation.

Authors:  W P Cheshire
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

4.  Effects of botulinum toxin induced muscle paralysis on endocytosis and lysosomal enzyme activities in mouse skeletal muscle.

Authors:  S Tågerud; R Libelius; S Thesleff
Journal:  Pflugers Arch       Date:  1986-09       Impact factor: 3.657

5.  Botulinum toxin: dangerous terminology errors.

Authors:  M F Brin; A Blitzer
Journal:  J R Soc Med       Date:  1993-08       Impact factor: 5.344

6.  Miniature end-plate potentials in rat skeletal muscle poisoned with botulinum toxin.

Authors:  Y I Kim; T Lømo; M T Lupa; S Thesleff
Journal:  J Physiol       Date:  1984-11       Impact factor: 5.182

7.  Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.

Authors:  J Jankovic; K Schwartz; D T Donovan
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

8.  Dithiobiuret neurotoxicity: an ultrastructural investigation of the lesion in preterminal axons and motor endplates in the rat lumbrical muscle.

Authors:  H B Jones
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  Transmitter release in tetanus and botulinum A toxin-poisoned mammalian motor endplates and its dependence on nerve stimulation and temperature.

Authors:  F Dreyer; A Schmitt
Journal:  Pflugers Arch       Date:  1983-11       Impact factor: 3.657

10.  Dependence of Clostridium botulinum gas and protease production on culture conditions.

Authors:  T J Montville
Journal:  Appl Environ Microbiol       Date:  1983-02       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.